Pfizer Stock News

Pfizer Jab & GSK''s Antibody Drug Are Effective Against Omicron After teasing various aspects of his plan to protect Americans from the omciron variant (which is arriving at the start of the latest ''winter wave'') while the CDC quietly collects names of travelers who recently visited southern Africa, President Joe Biden is preparing to share his plan, which will impose tighter restrictions on foreign travelers while extending a mask mandate and (potentially) double down on vaccine restrictions for American workers (even as multiple federal judges have rejected the mandate). Biden''s comments are expected later on Thursday, but during the early hours of the US session, Germany''s outgoing Chancellor Angela Merkel and her successor, Olaf Scholz, agreed on a plan to effectively mandate vaccinations by imposing stringent restrictions on Germans who haven''t voluntarily gotten the jab. As governments scramble to use omicron as an excuse to crack down on the unvaccinated, makers of vaccines and COVID remedies have continued to share data about their products'' efficacy at combating the omicron variant.

First Bancorp Inc ME purchased a new position in shares of Pfizer Inc. (NYSE:PFE) in the third quarter, Holdings Channel.com reports. The firm purchased 16,119 shares of the biopharmaceutical companys stock, valued at approximately $694,000. Several other institutional investors have also recently bought and sold shares of PFE. Mariner LLC grew its stake in shares []

While both vaccines were highly effective in preventing infection, hospitalization and death, the Moderna vaccine conferred a 21% lower risk of infection and a 41% lower risk of hospitalization.

THE OMICRON variant is causing a surge in cases in South Africa, increasing fears that it will soon supersede the Delta variant globally. An Israeli doctor, who caught the Omicron variant despite getting three shots of a Pfizer vaccine, has reported his three symptoms. Read more here Daily Express :: Health Feed Omicron variant: Doctors three Omicron symptoms despite having three doses of Pfizer

On November 15, The Food and Drug Administration (FDA) asked a federal judge to give it until the year 2076 to fully release all of the data and the documents the agency used as the basis for the approval and […] The post Over 1,200 vaccine deaths were reported within the first 90 days of Pfizer vaccine rollout, according to the first batch of Pfizer’s confidential documents released by the FDA following FOIA lawsuit appeared first on Tech News | Startups News .

The Omicron coronavirus variant has shaken up markets and caused global alarm over concerns about whether it could evade protection provided by widely used vaccines and prolong the public health crisis. Other vaccine makers including Moderna and Pfizer have also begun working on Omicron-tailored COVID-19 shots. Novavax''s COVID-19 vaccine received its first emergency use approval in Indonesia in early November followed by the Philippines.

NNA - The French Embassy in Lebanon on Thursday announced in a statement that "France has provided Lebanon with a donation of five hundred thousand doses of the Pfizer vaccine against the Covid-19 virus. French Ambassador to Lebanon, Mrs. Anne Grillo, had handed this grant to the Lebanese Minister of Health, Dr. Firas Al-Abyad, on Thursday, December 2, during a ceremony at the Rafic Hariri University Hospital in Beirut, in the presence of a number of United Nations organizations, representatives of the international community, and partners of the Ministry of Health, the statement added. =============R.H.

Futures Rebound Fizzles On Slowing iPhone Demand, Omicron Fears U.S. index futures regained some ground alongside Asian markets while European stocks slumped to session lows in a delayed response to yesterday''s late Omicron-driven US selloff, as markets remained volatile following the biggest two-day plunge in more than a year, spurred by concern about the omicron coronavirus variant and Federal Reserve tightening. Investors await data for unemployment claims, as well as earnings from companies including Dollar General and Kroger. Tech is the weakest sector, dropping in sympathy after Apple warned its suppliers of slowing iPhone demand. Nasdaq futures pared earlier gains of up to 0.8% to trade down 0.1% while S&P futures are only 0.2% higher after rising as much as 0.9%. While the knee-jerk reaction of stock investors may continue to be to take profits before the end of the year, there is plenty of liquidity available to drive stock prices higher as dip-buyers enter the market , Ed Yardeni wrote in a note.

COVID vaccine boosters will likely be needed every year in order to tackle the deadly virus, according to the Pfizer boss. It comes as the Omicron strain is spreading around the world with new cases found in Ireland, England, Scotland, the Netherlands, Denmark and Australia. Boss of pharmaceutical giant Pfizer, Dr Albert Bourla, claims a []

Ryan Teague Beckwith writes for Bloomberg that Democratic strategists see the future ruling(s) by the Supreme Court on abortion rights as an opportunity to rally Democratic base voters and suburban women. While abortion rights are a perennial issue in congressional campaigns, Democratic strategists say that the kind of major shift to restrict access signaled by the courts conservative majority in a case argued Wednesday would spur their base voters to turn out while moving swing voters away from the Republican Party. A court ruling is expected by the summer, giving Democrats a powerful pitch to raise money and recruit campaign volunteers as they head into the final stretch before the November elections. If the issue tipped the balance in even a few races, it could determine control of Congress, where Democrats currently have an eight-seat margin in the House and control the Senate only because of Vice President Kamala Harriss tie-breaking vote. Chris Hayden, a spokesman for the Democratic Congressional Campaign Committee, said that Republicans are in a bind because their base wants the Supreme Court to overturn Roe v.

Europes drug watchdog launched an accelerated review Thursday of a Covid-19 vaccine by Franco-Austrian biotech firm Valneva, for which the EU has already signed a deal for up to 60 million doses. The jab which uses inactivated viruses rather than the new mRNA technology of the Pfizer or Moderna shots showed in trials []

The British government has agreed on deals to buy 114 million more Pfizer Inc (NYSE: PFE ) / BioNTech SE (NASDAQ: BNTX ) and Moderna Inc (NASDAQ: MRNA ) COVID-19 vaccine shots. The new contracts with Pfizer/BioNTech and Moderna were accelerated in light of the emergence of the new Omicron variant. These future supply deals include access to modified vaccines, if needed, to combat Omicron and future Variants of Concern. The deal involves an additional 60 million Moderna shots and 54 million Pfizer/BioNTech doses for next year and 2023. "These new deals Full story available on Benzinga.com

It''s not all bad news.

THE HAGUE, Dec 2, 2021 (AFP) Europes drug watchdog launched an accelerated review Thursday of a Covid-19 vaccine by Franco-Austrian biotech firm Valneva, for which the EU has already signed a deal for up to 60 million doses. The jab which uses inactivated viruses rather than the new mRNA technology of the Pfizer or [] The post Franco-Austrian firm Valnevas Covid jab under EU review appeared first on BOL News .